RE:RE:Yes, "by way of tweet"
Ignore the paid basher. Their job was to drive it down from 75 cents to 25 cents. They succeeded. Now they want to slow the ascent back to 5 dollars so they can liquidate other positions and add. The simple fact is that their diagnostics coupled with Toraymyxin delivers the best results if sepsis is detected early ( with their device) and if Toraymyxin is administered fast. It has greater success in cases where the sepsis starts in the abdominal area. However given the high mortality rates of sepsis, the one-two punch of diagnostics plus toraymyxin does deliver a great result. Yes it is true that results fall off if the sepsis is discovered only a few days late. But given the high mortality rates of sepsis and how it shuts off organs quickly one cannot fault SDI if the medical hospitals are slow to detect it. The diagnostic gives results in 30 minutes after all. There is a bias in some medical literature that laments toraymyxin as not effective in late stage diagnostic and treatment and that is true, but early detection is the key in almost all diseases, so that's a mute point, or an idiot basher grasping for straws. The important point is that SDI has the diagnostic and the treatment and if both become standard operating procedure and are well inventoried in medical establishments this will be a huge winner. Again, there are no alternatives out there better now. Tell the FDA to tell the parent of a dead child you took away hope rather than take a chance. I think NOT. Winner winner or I'm a sinner.